VT BIO CO., LTD.

Close

Treg CELL THERAPY

DEVELOPMENT

VT BIO uses TTE01(Therapeutic Treg enhancer) system that can be used during many adaptations. This technology is a system that can separate, stimulate, and culture regulatory T cells, and is currently being developed as a dementia treatment for Alzheimer's disease.

Currently, the Preclinical pharmacological efficacy and the GLP toxicity assessment have been completed. It was approved by MFDS in August 2020 and is currently undergoing clinical trial phase 1 at Seoul National University Hospital.
top